Rallybio Corporation Common Stock

RLYBNASDAQ • USD
15.29 USD
↘ 0.13 (0.86%)🟢LIVE (AS OF 02:25 PM EST)
🟢Market: OPEN

RLYB is currently priced at $15.29. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (29.0%), a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics suggest RLYB is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 16, 2026.

Open?$15.35
High?$15.42
Low?$15.06
Prev. Close?$15.43
Volume?28.3K
Avg. Volume?28.2K
VWAP?$15.26
Rel. Volume?1.00x
Bid / Ask
Bid?$12.98 × 100
Ask?$17.50 × 100
Spread?$4.52
Midpoint?$15.24
Valuation & Ratios
Market Cap?86.4M
Shares Out?5.4M
Float?3.2M
Float %?61.0%
P/E Ratio?3.22
P/B Ratio?0.94
EPS?$4.79
Dividend?0.00%
Ex-Dividend?2026-11-23
News
Profile
Rallybio Corp is a clinical-stage biotechnology company comprised of experienced biopharma industry leaders with extensive research, development, and rare disease expertise with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. The company's program, RLYB116, is a differentiated complement component 5 (C5) inhibitor with the potential to treat diseases of complement dysregulation. The Company manages its operations as a single segment for the purposes of allocating resources, assessing performance, and making operating decisions. Rallybio's pipeline also includes RLYB332, a preclinical long-acting matriptase-2 antibody for the treatment of diseases of iron overload.
Employees
6
Market Cap
86.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-07-29
Address
234 CHURCH STREET
NEW HAVEN, CT 06510
Phone: 203- 859-3820
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
18
Short Sent.?
70
Piotroski F-Score?0/9Weak
Altman Z-Score?12.16Safe
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.20%Low
Short Interest?39.0K
Days to Cover?1.2
Free Float3.2M
Avg Daily Volume33.2K
Settlement Date2026-10-30
Financial Health
Current Ratio?28.87Strong
Quick Ratio?28.87Strong
Cash Ratio?27.63Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
89/100
P/E?
Peers
100
S&P
97
3.2CHEAP▾
P/B?
Peers
100
S&P
97
0.94CHEAP▾
P/S?
Peers
100
S&P
3
199.10HIGH▾
P/FCF?
Peers
100
S&P
97
2.8CHEAP▾
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP▾
EV/Sales?
S&P
97
-9.87CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
78
29.0%STRONG▾
ROA?
Peers
50
S&P
97
28.1%STRONG▾
Cash Flow & Enterprise
FCF?$31.0M
Enterprise Value?$-4285000
Fundamentals ratios updated end of day